Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies, Inc. (NYSE: MIR) reported a 2.3% decline in second-quarter revenues to $175.8 million, with a net loss of $59.3 million. Adjusted EBITDA fell 14.6% to $42.6 million, and adjusted EPS was $0.13. The company confirmed its 2022 expectations for organic adjusted revenue growth of 4%-6% and adjusted EBITDA of $170-$180 million. Order growth reached 25% in the first half, with a backlog of $693 million, despite a $55 million impairment due to project cancellations related to the Russia-Ukraine conflict.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Jefferies Industrials Conference in New York, NY, on Wednesday, August 10, 2022, at 1:00 PM ET. The presentation will be available via a live webcast, which can be accessed on their website under the 'Events and Presentations' section. An archived version will be posted within 12 hours post-event and will remain accessible for at least two weeks. Mirion specializes in detection and monitoring solutions across various end markets.
Mirion Technologies, Inc. (NYSE: MIR) will release its financial results for the second quarter of 2022 on Friday, July 29, 2022. The company will hold a conference call at 10:00 am ET to discuss these results. Interested participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784. A live webcast will also be available on the Mirion investor relations website. A telephonic replay will be accessible until August 12, 2022.
Mirion Technologies (NYSE: MIR) has announced the rebranding of its Medical segment to the Mirion Medical group, consolidating its healthcare-focused entities like Dosimetry Services and Sun Nuclear. This move aims to leverage expertise in ionizing radiation for healthcare applications, enhancing safety and efficiency for practitioners and patients. The new brand identity will feature a family logo, indicating unity among the different business units. This change will not affect how Mirion reports financial performance externally.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at CJS Securities’ 22nd Annual “New Ideas” Summer Conference in Greenwich, CT, on Tuesday, July 12, 2022. Mirion is a leader in detection, measurement, and monitoring solutions for the nuclear, defense, medical, and research sectors, emphasizing regulatory compliance and operational excellence. The company is headquartered in Atlanta, GA, and employs approximately 2,600 individuals across 13 countries.
Sun Nuclear Corporation, a subsidiary of Mirion Technologies (NYSE: MIR), will showcase its advanced quality management solutions for radiation therapy at the ESTRO 2022 Congress from May 6-10 in Copenhagen. Key highlights include the introduction of the SunSCAN™ 3D Cylindrical Water Scanning System, which enhances workflow efficiency and accuracy for stereotactic treatments. The SunCHECK™ Platform introduces a new SaaS option for easier deployment. Sun Nuclear also integrates CIRS technology for patient safety, with product demonstrations and educational sessions scheduled throughout the event.
Mirion Technologies, Inc. (NYSE: MIR) reported a 1.8% decrease in revenues for Q1 2022, totaling $163.2 million. The net loss improved to $19.0 million from $40.7 million year-over-year. Adjusted EBITDA fell 12.5% to $34.9 million. The company updated its 2022 guidance, forecasting organic adjusted revenue growth of 4%-6% and adjusted EBITDA of $170-$180 million. Despite challenges from supply chain issues and the Ukraine conflict, Mirion remains optimistic about its business strategy and order inflows.
Mirion Technologies, Inc. (NYSE: MIR) announced the release of the SunSCAN™ 3D cylindrical water scanning system by its subsidiary Sun Nuclear Corporation.
The system improves radiation therapy workflows, offering hyper-accurate dosimetry with a precision of 0.1 mm for stereotactic treatments. It features faster setup times and new SunDOSE™ software for enhanced quality assurance.
Demonstrations will take place at the ESTRO 2022 conference from May 6-10 in Copenhagen, with an online release event on May 17.
Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Goldman Sachs Industrials and Materials Conference on May 10, 2022, at 11:20 AM ET in New York, NY. The presentation will be available for live streaming on their website, with an archived version accessible for two weeks after the event. Mirion Technologies specializes in detection and monitoring solutions across various sectors, including nuclear and defense, and operates in 13 countries.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Wells Fargo’s 2022 Industrials Conference on Thursday, May 5, 2022, at 12:00 PM ET in New York, NY.
The presentation will be webcast live and accessible at Mirion's website, where it will be archived for two weeks following the event. Mirion provides detection, measurement, analysis, and monitoring solutions across various sectors, employing around 2,600 people globally.